Modeling programmable drug delivery in bioelectronics with electrochemical actuation

Drug delivery systems featuring electrochemical actuation represent an emerging class of biomedical technology with programmable volume/flowrate capabilities for localized delivery. Recent work establishes applications in neuroscience experiments involving small animals in the context of pharmacological response. However, for programmable delivery, the available flowrate control and delivery time models fail to consider key variables of the drug delivery system--microfluidic resistance and membrane stiffness. Here we establish an analytical model that accounts for the missing variables and provides a scalable understanding of each variable influence in the physics of delivery process (i.e., maximum flowrate, delivery time). This analytical model accounts for the key parameters--initial environmental pressure, initial volume, microfluidic resistance, flexible membrane, current, and temperature-to control the delivery and bypasses numerical simulations allowing faster system optimization for different in vivo experiments. We show that the delivery process is controlled by three non-dimensional parameters, and the volume/flowrate results from the proposed analytical model agree with the numerical results and experiments. These results have relevance to the many emerging applications of programmable delivery in clinical studies within the neuroscience and broader biomedical communities.

Automated summary

Drug delivery systems with electrochemical actuation offer programmable volume/flowrate capabilities for localized delivery. A new analytical model considering microfluidic resistance and membrane stiffness provides scalable understanding of key variables influencing the delivery process, allowing faster system optimization. The results show relevance to emerging applications of programmable delivery in clinical studies within the neuroscience and biomedical communities.